Reversible Gene Regulation in Mammalian Cells Using Riboswitch-Engineered Vesicular Stomatitis Virus Vector
- PMID: 31415142
- DOI: 10.1021/acssynbio.9b00177
Reversible Gene Regulation in Mammalian Cells Using Riboswitch-Engineered Vesicular Stomatitis Virus Vector
Abstract
Synthetic riboswitches based on small molecule-responsive self-cleaving ribozymes (aptazymes) embedded in the untranslated regions (UTRs) allow chemical control of gene expression in mammalian cells. In this work, we used a guanine-responsive aptazyme to control transgene expression from a replication-incompetent vesicular stomatitis virus (VSV) vector. VSV is a nonsegmented, negative-sense, cytoplasmic RNA virus that replicates without DNA intermediates, and its applications for vaccines and oncolytic viral therapy are being explored. By inserting the guanine-activated ribozyme in the 3' UTRs of viral genes and transgenes, GFP expression from the VSV vector in mammalian cells was repressed by as much as 26.8-fold in the presence of guanine. Furthermore, we demonstrated reversible regulation of a transgene (secreted NanoLuc) by adding and withdrawing guanine from the medium over the course of 12 days. In summary, our riboswitch-controlled VSV vector allows robust, long-term, and reversible regulation of gene expression in mammalian cells without the risk of undesirable genomic integration.
Keywords: RNA replicon; RNA virus; aptazyme; riboswitch.
Similar articles
-
Design of Mammalian ON-Riboswitches Based on Tandemly Fused Aptamer and Ribozyme.ACS Synth Biol. 2020 Jan 17;9(1):19-25. doi: 10.1021/acssynbio.9b00371. Epub 2019 Dec 16. ACS Synth Biol. 2020. PMID: 31820936
-
Circularly-Permuted Pistol Ribozyme: A Synthetic Ribozyme Scaffold for Mammalian Riboswitches.ACS Synth Biol. 2021 Aug 20;10(8):2040-2048. doi: 10.1021/acssynbio.1c00213. Epub 2021 Aug 10. ACS Synth Biol. 2021. PMID: 34374523
-
Synthetic mammalian riboswitches based on guanine aptazyme.Chem Commun (Camb). 2012 Jul 21;48(57):7215-7. doi: 10.1039/c2cc33140c. Epub 2012 Jun 13. Chem Commun (Camb). 2012. PMID: 22692003
-
Engineering of ribozyme-based riboswitches for mammalian cells.Methods. 2012 Mar;56(3):351-7. doi: 10.1016/j.ymeth.2012.01.005. Epub 2012 Jan 28. Methods. 2012. PMID: 22305857 Review.
-
Engineered riboswitches: Expanding researchers' toolbox with synthetic RNA regulators.FEBS Lett. 2012 Jul 16;586(15):2076-83. doi: 10.1016/j.febslet.2012.02.038. Epub 2012 Feb 28. FEBS Lett. 2012. PMID: 22710175 Review.
Cited by
-
An engineered ligand-responsive Csy4 endoribonuclease controls transgene expression from Sendai virus vectors.J Biol Eng. 2024 Jan 16;18(1):9. doi: 10.1186/s13036-024-00404-9. J Biol Eng. 2024. PMID: 38229076 Free PMC article.
-
Development of an RNA Virus-Based Episomal Vector Capable of Switching Transgene Expression.Front Microbiol. 2019 Nov 6;10:2485. doi: 10.3389/fmicb.2019.02485. eCollection 2019. Front Microbiol. 2019. PMID: 31781052 Free PMC article.
-
Scalable control of stem cell fate by riboswitch-regulated RNA viral vector without genomic integration.Mol Ther. 2025 Mar 5;33(3):1213-1225. doi: 10.1016/j.ymthe.2025.01.005. Epub 2025 Jan 10. Mol Ther. 2025. PMID: 39797398 Free PMC article.
-
Chemogenetic ON and OFF switches for RNA virus replication.Nat Commun. 2021 Mar 1;12(1):1362. doi: 10.1038/s41467-021-21630-5. Nat Commun. 2021. PMID: 33649317 Free PMC article.
-
Generation of a Tumor-Specific Chemokine Gradient Using Oncolytic Vesicular Stomatitis Virus Encoding CXCL9.Mol Ther Oncolytics. 2019 Dec 14;16:63-74. doi: 10.1016/j.omto.2019.12.003. eCollection 2020 Mar 27. Mol Ther Oncolytics. 2019. PMID: 31930167 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials